 |
Forrester has partnered with Employee Benefits News (EBN) to benchmark the role of technology in employers' vendor preferences, benefits administration, and benefits enhancement strategies. If you are a benefits executive, register your opinion online.
Respondents will receive a report of the results via email.
The fine print: This survey should take at most 20 minutes to complete. All responses are strictly confidential. We will not list individual or company names in any survey reports. All data will be reported in aggregate.
Liz Boehm will be speaking about measurement and analytic strategies that establish marketing ROI at the December 6, 2004, Pharmaceutical Marketing Executive Forum in Philadelphia.
Liz Boehm and Eric Brown will be crossing the pond to visit with European healthcare companies October 25-29, 2004. To schedule a meeting with Liz and Eric, contact Phil Tosney at ptosney@forrester.co.uk.
28. Percent of Internet users who have participated in online or offline behavior modification programs.
3 million. Dollars that misdiagnoses could cost a 600-bed hospital because of inappropriate admissions, corrective treatment, and increased length of hospital stay.
58. Percent of heart disease sufferers already using offline resources or the Net to research medical conditions or prescription medications.
62. Percent of doctors younger than 43, the median age of MDs in Forrester's 2004 Consumer Technographics Benchmark Study, who research specific medical devices online.
Clinical Trials' EDC Endgame by Eric Brown
Influencing Health Behavior Online by Liz Boehm
Search Sharpens Doctors' Diagnoses by Laura Ramos
Marketing To Heart Disease Patients by Sam Bishop
The Next Generation Of Wired Physicians by Eric Brown
Healthcare Unbound: Early Homecare Wins by Liz Boehm
Trends In Healthcare Consumer Technology Adoption
Who Pays For Healthcare Unbound by Liz Boehm
|
|
|
The EDC Endgame
Electronic data capture for clinical trials (EDC) is a hot topic for pharma and biotech executives. We applied the Forrester Wave¿ methodology to this emerging market to see how the leading vendors stack up. The results are in, but the field is shifting: Forrester predicts that EDC will be subsumed by suites of clinical systems to manage data, workflow, adverse events, and midstream reporting. Skeptical clinical trial managers who waited out the first round of buy-in will be looking for integrated clinical suites that supply an all-in-one solution.
During the past year, Forrester has been carefully watching the EDC story unfold. Last September, big deals with small vendors like Medidata Solutions and DataLabs demonstrated that there was more to EDC than Phase Forward's InForm and Oracle Clinical RDC. We applied Forrester's TechRankings™ methodology to EDC, diving deep into the features and functions, architecture, and study design elements that differentiate the eight leading vendors. This month's Clinical Trials' EDC Endgame is a snapshot of the 2004 EDC market and our view of what's to come.
|
ISABEL Helps Pediatricians Diagnose Rare Conditions
The tragic story of Isabel Maude's misdiagnosis inspired the clinical decision support system that bears her name. This Web-hosted search tool uses Autonomy's technology to recognize patterns of words in texts to help doctors consider alternative diagnoses without interrupting clinical workflow. More than averting tragedy, ISABEL will also save hospitals money on unnecessarily extended in-patient stays or treatments based on misdiagnoses.
Forrester's Consumer Forum 2004 In Review
Forrester's Consumer Technographics® "Benchmark 2004 Data Overview" showed that broadband access drives consumers' use and adoption of online tools for everything from banking transactions to checking the weather. These increasingly tech-savvy consumers have also figured out that spam filters and online ad-blockers to keep intrusive and irrelevant ads out of their online experience, and the ad-skipping feature of digital video recorders to excise TV program breaks. This consumer backlash against advertising means that marketers will have to go beyond the brand promises made in traditional ads. New analytical strategies grounded in deep audience knowledge, what Forrester calls "Left Brain Marketing," are the answer for marketers facing media fragmentation and ad-skipping consumers. Marketers who deliver targeted, scenario-based messages as they aid consumers in their search for information will win consumers' attention.
Pharma And Plans Are Turning To The Net To Promote Healthy Behavior
Online behavior modification is the arena where marketers' analytical techniques and understanding of consumer behavior intersect with health plans' disease management objectives and pharma's medication compliance programs. Faced with research that links lifestyle and disease, and the same media fragmentation that frustrates marketers, pharma and plans are revisiting the Net. Online behavior modification programs leverage the reach and cost effectiveness of the Internet to promote behavior changes that support good health -- and help control the cost of care. Healthcare players should take a page from the marketing book: Make analytics foundational, know your consumers' preferences, and integrate cross-channel initiatives for a unified customer experience.
We are very interested in your feedback on our research. Do you have topics to recommend, data you would like to have, or technologies you want assessed? Drop me a line at bradholmes@forrester.com so we can connect.
Brad Holmes
VP and Research Director,
Healthcare and Life Sciences
EMAIL: Email this issue to a colleague.
PRINT: View a printer-friendly version of this issue.
VIEW ARCHIVE: View past issues of First Look.
TECHNICAL SUPPORT: Call the Client Resource Center
1 866/FORRESTER (1 866/367-7378) or +1 617/613-5730.
EMAIL SUBSCRIPTIONS: If you'd like to subscribe or unsubscribe to First Look, please go to your Email Subscriptions page.
|
|
|
Entire contents 1997-2004, Forrester Research, Inc. All rights reserved.
Forrester, Forrester Oval Program, Forrester Wave, ForrTel, Forrester's
Ultimate Consumer Panel, WholeView 2, Technographics, TechRankings, and
Total Economic Impact are trademarks of Forrester Research, Inc. All other
trademarks are the property of their respective companies. Forrester
clients may make one attributed copy or slide of each figure contained
herein. Additional reproduction is strictly prohibited. For additional
reproduction rights and usage information, go to www.forrester.com.
Information is based on best available resources. Opinions reflect judgment
at the time and are subject to change.
Forrester Research, Inc., 400 Technology Square, Cambridge, MA 02139
|
